Sustained high glucose concentration drives excessive in situ activity of GCK, leading to the accumulation of glycolytic intermediates to abnormally high levels, which likely contributes to risk of MASLD. The gene discussed is GCK; the disease is metabolic dysfunction-associated steatotic liver disease.